BCR and B-cell non-Hodgkin lymphoma: In this study, we investigated the role of CD19, a crucial co-receptor for B-cell receptor (BCR) signaling, in the context of B-cell lymphomas, including aggressive forms like diffuse large B-cell lymphoma (DLBCL) and indolent forms like Waldenström Macroglobulinemia (WM).